Vaccine development remains central to reducing incident HIV globally, particularly where long-acting PrEP access is limited, ...

These results suggest that ruxolitinib cream offers high levels of clinical efficacy, including deep and rapid responses, ...

Jody L. Green, PhD, explains how regulatory decisions shape medication safety amid uptake of OTC drugs. Green also highlights ...

Despite these declines, CRC incidence is rising in adults younger than 65, increasing by 3% per year among patients aged 20 to 49 years and 0.4% per year among those aged 50 to 64 years. Consequently, ...

Real-world evidence shows Pluvicto matches pivotal trial benefits in PSMA-positive mCRPC, with longer PFS after one ARPI and delayed chemotherapy.

Povorcitinib 75 mg achieved high-threshold lesion clearance by week 12, including 100% draining-tunnel reduction in 12%–57% and total abscess clearance in 22%–62% of participants. Phase 3 data show ...

The gap in shared decision-making was similarly notable. Clinicians rated their own effectiveness in involving patients at 80.8 out of 100, while patients rated clinician involvement at only 69.1.

Advanced practice providers expand access by conducting initial consults, ordering diagnostic workups, explaining anti-amyloid risk–benefit tradeoffs, and coordinating multidisciplinary stakeholders ...

AI-enabled coronary CT angiography reveals total plaque burden beyond calcium scores, improving risk prediction and personalizing cardiovascular prevention.

Initiating add-on therapy within 2 years of a myasthenia gravis (MG) diagnosis was associated with a stronger and more consistent clinical response, according to a new study published in the Journal ...

Food-insecure adults have fewer annual health visits but rely more on telehealth for primary care, lowering per-visit costs, says Bidisha Mandal, PhD.

Standardized pediatric diabetes prevalence rose from 2.73 to 3.04 per 1,000 Medicaid/CHIP enrollees (2016–2021), reflecting an 11.4% relative increase with significant secular trend. Type 2 diabetes ...